Boston Scientific BSX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 275%-0.2pp | 274.5%-1.3pp | 274.1%-2.6pp | 274.5%-2.6pp | 275.2%-2.5pp | |
| Operating margin | 71.3%+7.5pp | 69.1%+4.8pp | 66.7%+1.4pp | 64.6%-0.6pp | 63.8%+1.2pp | |
| Net margin | 59.6%+13.8pp | 53.8%+7.6pp | 50.4%+4.0pp | 47.3%+3.2pp | 45.8%+6.8pp | |
| Returns | ||||||
| Return on equity | 51.7%+14.6pp | 46.5%+9.6pp | 42.9%+6.4pp | 39.3%+5.1pp | 37.1%+7.2pp | |
| Efficiency | ||||||
| Asset turnover | 1.9×+0.1× | 1.9×+0.1× | 1.9×+0.1× | 1.8×+0.1× | 1.8×+0.1× | |
| Liquidity | ||||||
| Current ratio | 6.4×+0.8× | 5.9×+0.1× | 5.4×-0.7× | 5.4×-0.6× | 5.6×-0.1× | |
| Per Share | ||||||
| Book value per share | $64.17+12.2% | $61.74+10.8% | $60.18+10.9% | $58.46+10.0% | $57.18+10.1% | |
| Valuation | ||||||
| Market capitalization | $533.31B+3.1% | $589.26B+25.7% | $579.55B+37.3% | $558.3B+48.5% | $517.48B+52.0% | |
| Price / earnings | 188.7×-87.5× | 236.2×-23.1× | 258.7×+17.5× | 275.8×+40.7× | 276.2×+18.0× | |
| Price / sales | 27.4×-4.2× | 31.3×+1.4× | 32.2×+4.2× | 32.4×+6.6× | 31.6×+7.3× | |
| Price / book | 22.5×-1.8× | 25.6×+3.0× | 25.8×+4.9× | 25.6×+6.5× | 24.3×+6.5× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Boston Scientific's profit margins?
- Boston Scientific (BSX) runs a 69.2% gross margin and a 18.4% operating margin, with a 17.3% net margin.
- Where do Boston Scientific's ratios come from?
- Every ratio is computed from Boston Scientific's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
